Sur vs Togo: Previously treated cases tested for RR-/MDR-TB
Sur
62.0%
in 2024
Togo
100.0%
in 2024
Sur rank
1st
Togo rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Sur
- Togo
How they compare
Togo currently reports 100.0% against 62.0% in Sur, a difference of 38.0%.
That makes Togo's figure about 1.6 times Sur's.
The two have swapped places 7 times across 16 shared years of data; in 2008 it was Sur ahead.
Sur ranks 1st and Togo ranks 1st of 1 regions.
Across the 3 decades both report, Sur averaged higher in 1 and Togo in 2.
Head to head by decade
| Decade | Sur | Togo | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 21.5% | 10.9% | 10.6% | Sur |
| 2010s | 53.0% | 61.3% | 8.3% | Togo |
| 2020s | 78.4% | 92.2% | 13.8% | Togo |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Sur or Togo?
- Togo, at 100.0% against 62.0% in Sur as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Sur and Togo?
- 38.0%, with Togo ahead.
- How many years of comparable data are there for Sur and Togo?
- 16 years are reported by both, from 2008 to 2024.
- How do Sur and Togo rank globally for previously treated cases tested for rr-/mdr-tb?
- Sur ranks 1st and Togo ranks 1st of 1 regions.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.